Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus

Saved in:
Bibliographic Details
Published in:ACR Open Rheumatology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553961132261376
collection WordPress RSS
FRELIP Feed Integration
container_title ACR Open Rheumatology
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:92070
institution FRELIP
journal_source_facet ACR Open Rheumatology
last_indexed 2026-06-20T21:45:12.453Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_alt El tratamiento a largo plazo con anifrolumab normaliza los parámetros hematológicos y varios marcadores serológicos en pacientes con lupus eritematoso sistémico
Le traitement à long terme par anifrolumab normalise les paramètres hématologiques et plusieurs marqueurs sérologiques chez les patients atteints de lupus érythémateux disséminé
Tratamento de Longo Prazo com Anifrolumabe Normaliza Parâmetros Hematológicos e Vários Marcadores Sorológicos em Pacientes com Lúpus Eritematoso Sistêmico
title_auth Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_es_txt El tratamiento a largo plazo con anifrolumab normaliza los parámetros hematológicos y varios marcadores serológicos en pacientes con lupus eritematoso sistémico
title_fr_txt Le traitement à long terme par anifrolumab normalise les paramètres hématologiques et plusieurs marqueurs sérologiques chez les patients atteints de lupus érythémateux disséminé
title_full Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_fullStr Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_full_unstemmed Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_pt_txt Tratamento de Longo Prazo com Anifrolumabe Normaliza Parâmetros Hematológicos e Vários Marcadores Sorológicos em Pacientes com Lúpus Eritematoso Sistêmico
title_short Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus
title_sort long‐term anifrolumab treatment normalizes hematologic parameters and several serologic markers in patients with systemic lupus erythematosus
topic Rheumatology
General
Rheumatology
url https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90065?af=R